U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

U.S. Food and Drug Administration
  1. Home
  2. Vaccines, Blood & Biologics
  3. ANTICOAGULANT SODIUM CITRATE 4% w/v SOLUTION, USP (STN 125697)
  1. Vaccines, Blood & Biologics

ANTICOAGULANT SODIUM CITRATE 4% w/v SOLUTION, USP (STN 125697)

STN: BA 125697
Proper Name: ANTICOAGULANT SODIUM CITRATE 4% w/v SOLUTION, USP
Trade Name: N/A
Manufacture: Laboratorios Grifols, S.A.
Indication:

  • Intended for use only with automated apheresis devices in the collection of human plasma or in performing therapeutic plasma exchange procedures. It is not to be infused directly into the donor.

Supporting Documents

Back to Top